THC-Infused Soft Lozenges Launching Exclusively at Apothecarium New Jersey Locations Immediately
NEW YORK and TORONTO, Sept. 2, 2021 /CNW/ – TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the East Coast launch of its premium edibles brand Valhalla Confections. The THC-infused soft lozenges (the “soft lozenges”) are exclusively available at the Company’s two New Jersey Apothecarium dispensaries located in Maplewood and Phillipsburg.
Valhalla’s soft lozenges gained popularity on the West Coast as one of the first precisely dosed ingestible products on the market. The lozenges are gluten-free and formulated with THC oil, terpenes and cannabinoids to deliver precise, discreet and convenient cannabis experiences. At launch, New Jersey medical patients will have access to three of the brand’s most popular flavors: Blue Raspberry, Sour Watermelon and Sweet Orange. Each package contains 35 lozenges, providing 10mg of THC per lozenge.
“Valhalla has developed a strong consumer following in California and we are thrilled to officially launch this exciting new form factor in New Jersey,” said Jason Wild, Executive Chairman of TerrAscend. “As we continue to build scale in our East Coast markets, I look forward to introducing additional product lines and categories that provide patients and adult-use consumers with desirable, high-quality products.”
“Valhalla Confections aim to provide consumers with delicious and accessible small-batch products that are precisely dosed and consistent,” said Ryan McWilliams, Executive Vice President at TerrAscend. “The East Coast launch of Valhalla’s THC-infused soft lozenges reflects TerrAscend’s dedication to developing and introducing world-class offerings that cater to the evolving needs of their diverse consumer base.”
To celebrate the brand launch, Valhalla team members will be on-site at both Apothecarium New Jersey locations today to educate and guide patients on safe use. For more information on Valhalla products in New Jersey, please visit https://apothecariumnj.com/.
The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.